Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs remifentanil for postoperative pain control after lumbar spine surgery
IRCT20241030063548N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Nov 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine and remifentanil in postoperative pain (2 arms), sponsored by Alborz University of Medical Sciences. Started Nov 2024; status: completed.
02
Drugs
dexmedetomidineremifentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20241030063548N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241030063548N1.